PTC Therapeutics, Inc. (PTCT)
69.45
-1.25
(-1.77%)
USD |
NASDAQ |
Feb 13, 16:00
69.39
-0.06
(-0.09%)
After-Hours: 20:00
PTC Therapeutics Cash from Investing (Quarterly) : -289.62M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -330.96M |
| Sarepta Therapeutics, Inc. | 232.40M |
| Spyre Therapeutics, Inc. | 25.00M |
| Keros Therapeutics, Inc. | -0.132M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -66.30M |
| Cash from Financing (Quarterly) | 15.22M |
| Free Cash Flow | 446.25M |
| Free Cash Flow Per Share (Quarterly) | -3.702 |
| Free Cash Flow to Equity (Quarterly) | -344.46M |
| Free Cash Flow to Firm (Quarterly) | -344.95M |
| Free Cash Flow Yield | 7.82% |